<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00267787</url>
  </required_header>
  <id_info>
    <org_study_id>ANAL0001</org_study_id>
    <secondary_id>95340</secondary_id>
    <secondary_id>ANAL0001</secondary_id>
    <nct_id>NCT00267787</nct_id>
  </id_info>
  <brief_title>Molecular Genetic and Pathological Studies of Anal Tumors</brief_title>
  <official_title>Molecular Genetic and Pathological Studies of Anal Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study the Genetics of Anal Cancer
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine the status of previously identified anal cancer molecular markers and any
      correlations with outcome as well as to discover new molecular biomarkers through correlating
      molecular data with clinical outcome. Study of tissue samples and cells from biopsies of your
      lesion and blood sample. We hope to learn the role genes and proteins may play in the
      development of anal cancer. Experiments will be performed using this tissue and blood,
      include analysis of DNA, analysis of RNA expression levels, analysis of protein levels of
      important gene products, and development of tissue culture cell lines.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2004</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Genetic analysis of blood sample as well as tissues , will provide us with any possible tumor marker for a better prognostic indicator.</measure>
    <time_frame>Annual assessment.</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Rectal Cancer</condition>
  <condition>Colon Cancer</condition>
  <condition>Colonic Neoplasms</condition>
  <condition>Anal Cancer</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>genetic analysis</intervention_name>
    <description>standard of care</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with anal cancer or high risk for anal cancer refered to Stanford.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:Inclusion Criteria:

          -  Patients with anal tumors

          -  Undergoing surgery for elective colon and rectal surgery

        Exclusion Criteria:No other patients other than adult patients with anal cancer or high
        risk for anal cancer refered to Stanford will be enrolled to the study. No Children will be
        included to the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Lane Welton</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Moe Jalali</last_name>
    <phone>(650) 724-4023</phone>
    <email>moej@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moe Jalali</last_name>
      <phone>650-724-4023</phone>
      <email>moej@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Cancer Clinical Trials Office</last_name>
      <phone>(650) 498-7061</phone>
    </contact_backup>
    <investigator>
      <last_name>Mark Lane Welton</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nader Pourmand</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr Andrew Shelton</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>George Albert Fisher M.D. Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James M Ford</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hanlee P. Ji</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2005</study_first_submitted>
  <study_first_submitted_qc>December 19, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2005</study_first_posted>
  <last_update_submitted>July 5, 2012</last_update_submitted>
  <last_update_submitted_qc>July 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 9, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anus Neoplasms</mesh_term>
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

